252 related articles for article (PubMed ID: 15667209)
1. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging.
Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O
Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209
[TBL] [Abstract][Full Text] [Related]
2. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
3. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
Ekström F; Akfur C; Tunemalm AK; Lundberg S
Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
5. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.
Carletti E; Li H; Li B; Ekström F; Nicolet Y; Loiodice M; Gillon E; Froment MT; Lockridge O; Schopfer LM; Masson P; Nachon F
J Am Chem Soc; 2008 Nov; 130(47):16011-20. PubMed ID: 18975951
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime.
Sanson B; Nachon F; Colletier JP; Froment MT; Toker L; Greenblatt HM; Sussman JL; Ashani Y; Masson P; Silman I; Weik M
J Med Chem; 2009 Dec; 52(23):7593-603. PubMed ID: 19642642
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.
Millard CB; Kryger G; Ordentlich A; Greenblatt HM; Harel M; Raves ML; Segall Y; Barak D; Shafferman A; Silman I; Sussman JL
Biochemistry; 1999 Jun; 38(22):7032-9. PubMed ID: 10353814
[TBL] [Abstract][Full Text] [Related]
8. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
9. Pressure and propylene carbonate denaturation of native and "aged" phosphorylated cholinesterase.
Masson P; Gouet P; Clery C
J Mol Biol; 1994 May; 238(3):466-78. PubMed ID: 8176737
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of oxime-bound fenamiphos-acetylcholinesterases: reactivation involving flipping of the His447 ring to form a reactive Glu334-His447-oxime triad.
Hörnberg A; Artursson E; Wärme R; Pang YP; Ekström F
Biochem Pharmacol; 2010 Feb; 79(3):507-15. PubMed ID: 19732756
[TBL] [Abstract][Full Text] [Related]
11. A step toward the reactivation of aged cholinesterases--crystal structure of ligands binding to aged human butyrylcholinesterase.
Wandhammer M; de Koning M; van Grol M; Loiodice M; Saurel L; Noort D; Goeldner M; Nachon F
Chem Biol Interact; 2013 Mar; 203(1):19-23. PubMed ID: 22922115
[TBL] [Abstract][Full Text] [Related]
12. Direct observation and elucidation of the structures of aged and nonaged phosphorylated cholinesterases by 31P NMR spectroscopy.
Segall Y; Waysbort D; Barak D; Ariel N; Doctor BP; Grunwald J; Ashani Y
Biochemistry; 1993 Dec; 32(49):13441-50. PubMed ID: 8257680
[TBL] [Abstract][Full Text] [Related]
13. Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation.
Carletti E; Colletier JP; Dupeux F; Trovaslet M; Masson P; Nachon F
J Med Chem; 2010 May; 53(10):4002-8. PubMed ID: 20408548
[TBL] [Abstract][Full Text] [Related]
14. A computational study of the deacylation mechanism of human butyrylcholinesterase.
Suárez D; Díaz N; Fontecilla-Camps J; Field MJ
Biochemistry; 2006 Jun; 45(24):7529-43. PubMed ID: 16768449
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
16. Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases.
Nachon F; Carletti E; Worek F; Masson P
Chem Biol Interact; 2010 Sep; 187(1-3):44-8. PubMed ID: 20381476
[TBL] [Abstract][Full Text] [Related]
17. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
18. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
19. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.
Samanta U; Kirby SD; Srinivasan P; Cerasoli DM; Bahnson BJ
Biochem Pharmacol; 2009 Aug; 78(4):420-9. PubMed ID: 19394314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
